EContra EZ can be used up to 72 hours after unprotected sex or suspected contraceptive failure, but is said to be more effective the sooner it is taken.
This is the sixth drug and the second emergency contraceptive to join the company’s portfolio of FDA-approved and branded generic oral and emergency contraceptive products.
With the recent launch, the company now becomes the only US pharmaceutical firm to offer both OTC and prescription emergency contraceptives.
In 2014, the company introduced ella (ulipristal acetate), a prescription progesterone agonist/antagonist emergency contraceptive that is effective at delaying or preventing ovulation for up to five days after unprotected sex or birth control failure.
Afaxys president and CEO Ronda Dean said: "Women need an emergency contraceptive they can depend on.
"At Afaxys, as experts in emergency contraceptives, we understand how intimidating and confusing the process can be.
"EContra EZ is safe and effective and easy to use and is readily accessed through the public health sector without a prescription, giving control to women at a time when they desire it most."
Currently, EContra EZ is widely available to women who obtain their women’s health products through the public health sector which includes Planned Parenthood, family planning clinics, and Student Health Centers at colleges and universities.